Lyfegen

✨Happy Holidays from all of us at Lyfegen! ✨ This festive season, we want to thank you for being an essential part of our journey. Your support inspires us to continue bridging the gap to faster and smarter access in healthcare. As we look ahead to 2025, we’re excited to deliver innovative solutions that redefine what’s possible. Here’s to a joyful holiday season and a successful year ahead! Wishing you and your loved ones happiness, health, and prosperity. #Lyfegen

Gene therapies are transforming medicine, offering hope for patients with genetic conditions like hemophilia and spinal muscular atrophy. But their high costs bring both opportunities and challenges for pharma, payers, and healthcare systems. Are you prepared? Our latest blog explores how these revolutionary treatments are reshaping the healthcare landscape and highlights key solutions: 1️⃣ Outcome-based payments: Track real-world results to ensure value-based reimbursements. 2️⃣ Proven agreement models: Access over 6,700 public contracts to guide smarter negotiations. 3️⃣ Innovative pricing simulations: Design flexible payment models, from installments to subscription-style contracts. 💡 Book a demo today and discover how Lyfegen’s tools align cost with outcomes for better patient care: https://lnkd.in/dn6Nh7sh 👉 What’s your take on the rise of gene therapies? Share your thoughts in the comments or tag a colleague who should see this. #GeneTherapies #DrugPricing #ValueBasedAgreements #Pharma #HealthcareInnovation #Lyfegen

We’re proud to share our poster presented at ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024, showcasing how Lyfegen partnered with NL Health Services to recover $𝟲𝟬𝟬,𝟬𝟬𝟬 𝗖𝗔𝗗 𝗶𝗻 𝗺𝗶𝘀𝘀𝗲𝗱 𝗿𝗲𝗯𝗮𝘁𝗲𝘀 and reinvest them into life-saving oncology treatments. 📖 Key Highlights Include: ✅ Automation of rebate processes for efficiency and accuracy ✅ Identification of hidden rebates through advanced analysis ✅ Reinvestment of savings to improve patient access to innovative therapies 🔗 Explore our work in the ISPOR Presentation Database: https://lnkd.in/e_8na6De 📥 Want the full version of the poster? Download it here: https://lnkd.in/enHhEXcs 💬 Have questions? Reach out directly to Ina Hasani, MSc, MBA, for more details. #HealthcareInnovation #OncologyManagement #RebateManagement #ValueBasedHealthcare #ISPOR2024 #HealthEconomics #PatientAccess #DrugPricing #PharmaSolutions #HealthcareTransformation

🚨 Breaking News: Lyfegen Secures additional 𝗖𝗛𝗙 𝟱 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗦𝗲𝗿𝗶𝗲𝘀 𝗔 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 to Scale Its Drug Rebate Management Platform Globally 🚨 We’re excited to announce our successful CHF 5 million Series A funding round, led by TX Ventures and additional participation from aMoon Fund, and other institutional investors. “This funding positions us to tackle the growing complexity of drug pricing and rebate agreements, ultimately empowering stakeholders to ensure patients have access to the treatments they need,” says Girisha Fernando, CEO of Lyfegen. This marks a significant milestone in Lyfegen’s mission to bring greater efficiency and cost savings to healthcare systems worldwide, ultimately transforming how care is delivered. Read the full press release 👉🏽 https://lnkd.in/dsVwPjDZ #Lyfegen #HealthcareInnovation #DrugPricing #HealthTech #SeriesAFunding #GlobalExpansion #PatientAccess #DigitalHealth #RebateManagement #HealthcareTransformation #ValueBasedHealthcare

Rare disease treatments come with unique challenges—are you ready to address them? In our latest blog, we explore how Outcomes-Based Agreements (OBAs) are transforming the landscape for rare disease therapies. Here are 3 key insights: 1️⃣ OBAs align costs with real-world outcomes, helping mitigate the financial risks of high-cost therapies like CAR-T treatments. 2️⃣ Challenges like data collection, administrative complexity, and collaboration require robust frameworks for successful implementation. 3️⃣ Tools like Lyfegen’s Agreements Library and Drug Contracting Simulator simplify the planning, execution, and management of OBAs for better outcomes. Prepare your team to tackle rare disease treatment challenges with confidence—read the blog and discover how Lyfegen can support you by booking a demo with us today: lyfegen.com/demo #RareDiseases #HealthcareInnovation #OutcomesBasedAgreements #PharmaSolutions #ValueBasedCare #Lyfegen

Perfect timing for big plans! Last week, our Lyfegen team came together in vibrant Lisbon, Portugal, for an inspiring global gathering. It was the ideal moment to reflect on this year’s achievements and plan for an even more successful 2025. From strategy workshops to collaborative sessions, we used this time to align, innovate, and prepare for what’s ahead. Lisbon provided the perfect backdrop to set the stage for the exciting opportunities the new year will bring. Together, we’re ready to make it happen! #Lyfegen #LyfegenTeam #2025Ready #TeamBuilding

This is why we do what we do every day at Lyfegen. Behind every drug access negotiation lies a story—real lives affected by barriers that we believe should no longer exist. Read more about how we’re bridging the gap to faster, smarter access to life-saving treatments for those who need them most. #HealthInnovation #AccessToCare #Lyfegen

𝗬𝗲𝘀𝘁𝗲𝗿𝗱𝗮𝘆, 𝗼𝗻 𝗪𝗼𝗿𝗹𝗱 𝗔𝗜𝗗𝗦 𝗗𝗮𝘆, we reflected on the progress made and the challenges ahead in the fight against HIV/AIDS, which affects over 38 million people globally. Despite advancements in antiretroviral therapies, millions still face barriers to accessing life-saving treatments. The question remains: how do we close these gaps and ensure better care for more patients? One answer lies in innovation and collaboration. 𝗟𝘆𝗳𝗲𝗴𝗲𝗻’𝘀 𝗔𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁𝘀 𝗟𝗶𝗯𝗿𝗮𝗿𝘆 offers a powerful solution, featuring 𝟭𝟮𝟰 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁𝘀 for HIV/AIDS treatments, including groundbreaking drugs like 𝗕𝗶𝗸𝘁𝗮𝗿𝘃𝘆, 𝗦𝘂𝗻𝗹𝗲𝗰𝗮, 𝗧𝗶𝘃𝗶𝗰𝗮𝘆, 𝗣𝗶𝗳𝗲𝗹𝘁𝗿𝗼, and 𝗣𝗿𝗲𝘇𝗶𝘀𝘁𝗮. These agreements drive access and improve patient outcomes globally. 𝗟𝗲𝘁’𝘀 make progress together. Don’t miss out on how Lyfegen is transforming access to life-saving treatments—𝗯𝗼𝗼𝗸 𝗮 𝗱𝗲𝗺𝗼 𝘁𝗼𝗱𝗮𝘆: https://hubs.la/Q02ZX8wl0 #WorldAIDSDay #HIVAIDSAwareness #InnovativeTreatments #HealthcareAccess #Lyfegen #LyfegenLibrary #Biktarvy #Sunleca #Tivicay #Pifeltro #Prezista #PharmaSolutions #GlobalHealth #PatientCare

💼 As the year winds down, many of us are looking to make the most of our budgets and set ourselves up for a strong start next year. At Lyfegen, we’re all about helping teams make informed, strategic decisions that drive long-term value. Our Library and Simulator are designed to support efficient decision-making by offering insights that would usually require a team of consultants. With access to 6,700+ public agreements, real-time scenario comparisons, and flexible contracting models, we’re helping organizations stay agile and prepared for what’s ahead. Book a demo now to optimize your strategies and make the most of your resources before year-end 👉https://hubs.la/Q02Z0R480 #BudgetPlanning #MarketAccess #Pharma #PricingStrategy #HealthcareInnovation #Lyfegen

Are you still relying on outdated methods for pricing and market access strategies? It’s time for a change. 𝗟𝘆𝗳𝗲𝗴𝗲𝗻’𝘀 𝗗𝗿𝘂𝗴 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝘁𝗶𝗻𝗴 𝗦𝗶𝗺𝘂𝗹𝗮𝘁𝗼𝗿 is the tool designed to keep your Market Access and Pricing teams ahead of the curve. With growing pricing pressures and the need for faster decisions, this simulator 𝗲𝗺𝗽𝗼𝘄𝗲𝗿𝘀 𝘆𝗼𝘂 𝘁𝗼 𝗺𝗮𝗸𝗲 𝗱𝗮𝘁𝗮-𝗱𝗿𝗶𝘃𝗲𝗻 𝗰𝗵𝗼𝗶𝗰𝗲𝘀 and 𝗻𝗮𝘃𝗶𝗴𝗮𝘁𝗲 𝗰𝗼𝗺𝗽𝗹𝗲𝘅 𝗽𝗿𝗶𝗰𝗶𝗻𝗴 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲𝘀 with confidence. 💡 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁𝗹𝘆 𝗺𝗼𝗱𝗲𝗹 𝗽𝗿𝗶𝗰𝗶𝗻𝗴 𝘀𝗰𝗲𝗻𝗮𝗿𝗶𝗼𝘀: Quickly build and test various drug rebate contracts to understand their impact on your gross-to-net revenue and costs. 🤝 𝗣𝘂𝗿𝗽𝗼𝘀𝗲-𝗯𝘂𝗶𝗹𝘁 𝗳𝗼𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: Move beyond Excel with a platform tailored for Market Access and Pricing teams, enabling seamless collaboration across different markets and assets. ⚡ 𝗦𝗽𝗲𝗲𝗱 𝘂𝗽 𝘆𝗼𝘂𝗿 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁𝘀: Respond to market changes faster and create better rebate agreements that meet the demands of an evolving landscape. Don’t wait—pricing pressures are rising, and the need for smarter, faster decisions is now. Stay ahead, 𝗯𝗼𝗼𝗸 𝘆𝗼𝘂𝗿 𝗱𝗲𝗺𝗼 with us today: https://hubs.la/Q02Z0SH50 #pharma #marketaccess #drugpricing #negotiation #healthcare #pricingstrategy #Lyfegen #LyfegenSimulator #PricingModels